Full-Time

Program Manager

Absci

Absci

51-200 employees

AI and synthetic biology for drug discovery and production

Data & Analytics
AI & Machine Learning
Biotechnology

$85,000 - $120,000

Equity, Annual Bonus

Junior, Mid

Vancouver, WA, USA

Required Skills
Communications
Management
Requirements
  • BS/PhD Degree in a Science related field and 2+ years experience in a biotech related field or equivalent technical work experience
  • Working knowledge of project management software (MS Project, SmartSheet, etc.)
  • Familiar with workflows involving: protein engineering, cloning, high-throughput screening, protein purification, and analytical chemistry
  • Proven experience with Change Management and Conflict Resolution with a proactive mindset
Responsibilities
  • Support our innovation strategy by planning activities, tracking activities, and holding stakeholders accountable for project tasks and deadlines.
  • Simultaneously balance activities between multiple projects of various scopes.
  • Estimate and manage the costs and time to complete the work within budget and timeline, and track all activities using project management software.
  • Define the project team's structure and culture and use technology to ensure essential communication between groups in business processes and during experimental handoffs.
  • Identify, assess, prioritize & manage project-related risks and clearly present solutions that link directly to the key program objectives.
  • Work with stakeholders and scientific leadership to understand failure modes and implement corrective actions while working to build a system where operational activities are increasingly automatic and seamless.

Absci stands out as a leading company in the biotech industry, leveraging deep learning AI and synthetic biology to expand the therapeutic potential of proteins, which allows for the creation of protein-based drugs that may not be possible with other technologies. Their Integrated Drug Creation™ Platform streamlines the process of drug discovery and manufacturing, offering a unique competitive advantage. Furthermore, their zero-shot AI approach designs antibodies from scratch, potentially reducing the time to get new drug leads into the clinic and unlocking treatments for traditionally "undruggable" diseases.

Company Stage

IPO

Total Funding

$324.3M

Headquarters

Vancouver, Washington

Founded

2011

Growth & Insights
Headcount

6 month growth

-4%

1 year growth

-12%

2 year growth

-14%